As shown in Fig. 4b, the differences are statistically significant, indicating that precancer antiviral therapy decreases MVI occurrence and tumor satellite micronodules, and improve the prognosis of HCC maybe by manipulating the expression of CK18, GPC3 or OPN. Here, KRT18 is linked to hepatocellular carcinoma.